p.42 抽出テキスト

dial Perfusion Imaging Using 99mTc Pharmaceuticals in Japan: Results from a Nationwide Survey. Asia Ocean J Nucl Med Biol 2018; 6: 90-96. PMID: 29998141 75. Einstein AJ, Pascual TN, Mercuri M, et al. INCAPS Investigators Group. Current worldwide nuclear cardiology practices and radiation exposure: results from the 65 country IAEA Nuclear Cardiology Protocols Cross-Sectional Study (INCAPS). Eur Heart J 2015; 36: 1689-1696. PMID: 25898845 75a. Cerqueira MD, Allman KC, Ficaro EP, et al. Recommendations for reducing radiation exposure in myocardial perfusion imaging. J Nucl Cardiol 2010; 17: 709-718. PMID: 20503120 76. Danad I, Szymonifka J, Schulman-Marcus J, et al. Static and dynamic assessment of myocardial perfusion by computed tomography. Eur Heart J Cardiovasc Imaging 2016; 17: 836-844. PMID: 27013250 77. Vonder M, van der Werf NR, Leiner T, et al. The impact of dose reduction on the quantification of coronary artery calcifications and risk categorization: A systematic review. J Cardiovasc Comput Tomogr 2018; 12: 352-363. PMID: 29960743 78. Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 guideline update for exercise testing: Summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Am Coll Cardiol 2002; 40: 1531-1540. PMID: 12392846 79. Fletcher GF, Ades PA, Kligfield P, et al. Exercise standards for testing and training: A scientific statement from the American Heart Association. Circulation 2013; 128: 873-934. PMID: 23877260 80. Rozanski A, Gransar H, Min JK, et al. Long-term mortality following normal exercise myocardial perfusion SPECT according to coronary disease risk factors. J Nucl Cardiol 2014; 21: 341-350. PMID: 24379127 81. Douglas PS, Hoffmann U, Patel MR, et al. PROMISE Investigators. Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med 2015; 372: 1291-1300. PMID: 25773919 82. Budoff MJ, Mayrhofer T, Ferencik M, et al. PROMISE Investigators. Prognostic Value of Coronary Artery Calcium in the PROMISE Study (Prospective Multicenter Imaging Study for Evaluation of Chest Pain). Circulation 2017; 136: 1993-2005. PMID: 28847895 83. Noto TJ Jr, Johnson LW, Krone R, et al. Cardiac catheterization 1990: A report of the Registry of the Society for Cardiac Angiography and Interventions (SCA&I). Cathet Cardiovasc Diagn 1991; 24: 75-83. PMID: 1742788 84. CASS principal investigators and their associates. Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data. Circulation 1983; 68: 939-950. PMID: 6137292 85. Serruys PW, Morice MC, Kappetein AP, et al. SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009; 360: 961-972. PMID: 19228612 86. Nam CW, Mangiacapra F, Entjes R, et al. FAME Study Investigators. Functional SYNTAX score for risk assessment in multivessel coronary artery disease. J Am Coll Cardiol 2011; 58: 1211-1218. PMID: 21903052 87. Farooq V, van Klaveren D, Steyerberg EW, et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet 2013; 381: 639-650. PMID: 23439103 88. Takahashi K, Serruys PW, Fuster V, et al. SYNTAXES, FREEDOM, BEST, and PRECOMBAT trial investigators. Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation. Lancet 2020; 396: 1399-1412. PMID: 33038944 89. Meijboom WB, Van Mieghem CA, van Pelt N, et al. Comprehensive assessment of coronary artery stenoses: computed tomography coronary angiography versus conventional coronary angiography and correlation with fractional flow reserve in patients with stable angina. J Am Coll Cardiol 2008; 52: 636-643. PMID: 18702967 90. Lopes RD, Alexander KP, Stevens SR, et al. Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease in Patients With a History of Heart Failure or Left Ventricular Dysfunction: Insights From the ISCHEMIA Trial. Circulation 2020; 142: 1725-1735. PMID: 32862662 91. Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS

Guidelines on myocardial revascularization. The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2019; 40: 87-165. PMID: 30165437 92. Kawase Y, Matsuo H, Akasaka T, et al. Clinical use of physiological

lesion assessment using pressure guidewires: an expert consensus document of the Japanese Association of Cardiovascular Intervention and Therapeutics. Cardiovasc Interv Ther 2019; 34: 85-96. PMID: 30588572 93. De Bruyne B, Fearon WF, Pijls NH, et al. FAME 2 Trial Investigators. Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med 2014; 371: 1208-1217. PMID: 25176289 94. Tanaka N, Nakamura M, Akasaka T, et al. CVIT-DEFER Registry Investigators. One-Year Outcome of Fractional Flow Reserve-Based Coronary Intervention in Japanese Daily Practice - CVIT-DEFER Registry. Circ J 2017; 81: 1301-1306. PMID: 28450667 95. Xaplanteris P, Fournier S, Pijls NHJ, et al. FAME 2 Investigators. Five-Year Outcomes with PCI Guided by Fractional Flow Reserve. N Engl J Med 2018; 379: 250-259. PMID: 29785878 96. Zimmermann FM, Ferrara A, Johnson NP, et al. Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial. Eur Heart J 2015; 36: 3182-3188. PMID: 26400825 97. van Nunen LX, Zimmermann FM, Tonino PA, et al. FAME Study Investigators. Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial. Lancet 2015; 386: 1853-1860. PMID: 26333474 98. Usui Y, Chikamori T, Yanagisawa H, et al. Reliability of pressure-derived myocardial fractional flow reserve in assessing coronary artery stenosis in patients with previous myocardial infarction. Am J Cardiol 2003; 92: 699-702. PMID: 12972110 99. Fournier S, Toth GG, De Bruyne B, et al. Six-Year Follow-Up of Fractional Flow Reserve-Guided Versus Angiography-Guided Coronary Artery Bypass Graft Surgery. Circ Cardiovasc Interv 2018; 11: e006368. PMID: 29848611 100. De Bruyne B, Pijls NH, Bartunek J, et al. Fractional flow reserve in patients with prior myocardial infarction. Circulation 2001; 104: 157-162. PMID: 11447079 101. Hamilos M, Muller O, Cuisset T, et al. Long-term clinical outcome after fractional flow reserve-guided treatment in patients with angiographically equivocal left main coronary artery stenosis. Circulation 2009; 120: 1505-1512. PMID: 19786633 102. Glineur D, Grau JB, Etienne PY, et al. Impact of preoperative fractional flow reserve on arterial bypass graft anastomotic function: the IMPAG trial. Eur Heart J 2019; 40: 2421-2428. PMID: 31155673 103. Ntalianis A, Sels JW, Davidavicius G, et al. Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction. JACC Cardiovasc Interv 2010; 3: 1274-1281. PMID: 21232721 104. Van Belle E, Gil R, Klauss V, et al. Impact of Routine Invasive Physiology at Time of Angiography in Patients With Multivessel Coronary Artery Disease on Reclassification of Revascularization Strategy: Results From the DEFINE REAL Study. JACC Cardiovasc Interv 2018; 11: 354-365. PMID: 29471949 105. Ahn JM, Park DW, Shin ES, et al. IRIS-FFR Investigators. Fractional Flow Reserve and Cardiac Events in Coronary Artery Disease: Data From a Prospective IRIS-FFR Registry (Interventional Cardiology Research Incooperation Society Fractional Flow Reserve). Circulation 2017; 135: 2241-2251. PMID: 28356440 106. Johnson NP, Tóth GG, Lai D, et al. Prognostic value of fractional flow reserve: Linking physiologic severity to clinical outcomes. J Am Coll Cardiol 2014; 64: 1641-1654. PMID: 25323250 107. Sud M, Han L, Koh M, et al. Association Between Adherence to Fractional Flow Reserve Treatment Thresholds and Major Adverse Cardiac Events in Patients With Coronary Artery Disease. JAMA 2020; 324: 2406-2414. PMID: 33185655 108. Weerts J, Pustjens T, Amin E, et al. Long-term outcome after deferred revascularization due to negative fractional flow reserve in intermediate coronary lesions. Catheter Cardiovasc Interv 2021; 97: 247-256. PMID: 31999077 109. Depta JP, Patel JS, Novak E, et al. Risk model for estimating the 1-year risk of deferred lesion intervention following deferred revascularization after fractional flow reserve assessment. Eur Heart J 2015; 36: 509-515. PMID: 25336221 110. Van Belle E, Rioufol G, Pouillot C, et al. Investigators of the Registre Français de la FFR–R3F. Outcome impact of coronary revascularization strategy reclassification with fractional flow reserve at time of diagnostic angiography: Insights from a large French multicenter fractional flow reserve registry. Circulation 2014; 129: 173- 185. PMID: 24255062 111. Escaned J, Collet C, Ryan N, et al. Clinical outcomes of state-of-